Nosocomial infection, the deficit reduction act, and incentives for hospitals

JAMA

Volumn 300, Issue 13, 2008, Pages 1577-1579

  Graves, Nicholas ^a   McGowan, John E ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN;

CATHETER INFECTION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION; INFECTION CONTROL; MEDICAID; MEDICAL DECISION MAKING; MEDICARE; NOTE; PRIORITY JOURNAL; REIMBURSEMENT; SURGICAL INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; ARTICLE; COST; CROSS INFECTION; ECONOMICS; GOVERNMENT; HEALTH ECONOMICS; HUMAN; STANDARD; UNITED STATES;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); COSTS AND COST ANALYSIS; CROSS INFECTION; ECONOMICS, HOSPITAL; HUMANS; INFECTION CONTROL; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 54849148700     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.13.1577     Document Type: Note

References (14)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
2. Centers for Medicare & Medicaid Services. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates; payments for graduate medical education in certain emergency situations; changes to disclosure of physician ownership in hospitals and physical self-referral rules; updates to the long-term care prospective payment system; updates to certain IPPS-excluded hospitals; and collection of information regarding financial relationships between hospitals; final rule. Fed Regist. 2008;73(161):48434-49083.
3. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for "preventable complications." JAMA. 2008;299(18):2197-2199.
4. Anderson DJ, Kirkland KB, Kaye KS, et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol. 2007;28(7):767-773.
5. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis. 2004;10(4):561-566.
6. Davis MM. Challenges in cost-effectiveness analyses of hospital interventions to improve quality. Infect Control Hosp Epidemiol. 2008;29(5):395-397.
7. Zell BL, Goldmann DA. Healthcare-associated infection and antimicrobial resistance: moving beyond description to prevention. Infect Control Hosp Epidemiol. 2007;28(3):261-264.
8. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control. 2007;35(5):290-301.
9. Persson U, Persson M, Malchau H. The economics of preventing revisions in total hip replacement. Acta Orthop Scand. 1999;70(2):163-169.
10. Roberts RR, Frutos PW, Ciavarella GC, et al. Distribution of fixed vs variable costs of hospital care. JAMA. 1999;281(7):644-649.
11. Halton K, Graves N. Economics of preventing catheter-related bloodstream infection? Emerg Infect Dis. 2007;13(6):815-823.
12. Burke JP. Infection control: a problem for patient safety. N Engl J Med. 2003;348(7):651-657.
13. Laxminarayan R, Malani A, Howard D, et al. Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance. Washington, DC: Resources for the Future; 2007.
14. Clements A, Halton K, Graves N, et al. Overcrowding and understaffing in modern healthcare systems: key determinants in MRSA transmission. Lancet Infect Dis. 2008;8(7):427-434.